Lindsey Elizabeth Roeker (Lindsey E Roeker, Lindsey Roeker)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Topics

Chronic Lymphocytic Leukemia

End Stage Renal Disease

Ejection Fraction

Tyrosine Kinase

Top Venues

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Yannis K Valtis, David Nemirovsky, Andriy Derkach, Saumya Sharan, Charlene Claire Kabel, Ricardo Ortiz, Meghan C Thompson, Lindsey Elizabeth Roeker, Mark Blaine Geyer
Real-world incidence and prevention of tumor lysis syndrome in chronic lymphocytic leukemia treated with venetoclax. Blood advances (2024)
Laura Samples, Jenna M Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan C Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel A Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted A Gooley, Kellie Ryan, Frederick Lansigan, Brian T Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study. Blood advances (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Laura Samples, Jenna M Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E Spurgeon, Deborah M Stephens, Alan P Skarbnik, Anthony R Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan C Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel A Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted A Gooley, Kellie Ryan, Frederick Lansigan, Brian T Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension Treatment in Patients Receiving Ibrutinib: A Multicenter Retrospective Study. Blood advances (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Lindsey Elizabeth Roeker
A fresh look at covalent BTK inhibitor resistance. Blood 144 (10) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Laura Samples, Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen Spurgeon, Deborah M Stephens, Alan Skarbnik, Anthony Mato, Catherine Broome, Ajay K Gopal, Stephen Douglas Smith, Ryan Lynch, Magdalena A Rainey, Myung Sun Kim, Odeth Barrett-Campbell, Emily Hemond, Mazie Tsang, Daniel Ermann, Nikita Malakhov, Danielle Rao, Mehrdad Shakib-Azar, Beth Morrigan, Ayushi Chauhan, Thomas Plate, Ted Gooley, Kellie Ryan, Frederick Lansigan, Brian Hill, Georgios Pongas, Sameer A Parikh, Lindsey Elizabeth Roeker, John N Allan, Richard K Cheng, Chaitra S Ujjani, Mazyar Shadman
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study. Blood advances 8 (9) (2024)
Lindsey Elizabeth Roeker, Jennifer A Woyach, Chan Yoon Y Cheah, Catherine C Coombs, Nirav N Shah, William G Wierda, Manish R Patel, Nicole Lamanna, Donald E Tsai, Binoj Chandrasekharan Nair, Chunxiao Wang, Xiang Zhao, Dan Liu, David Radtke, Sonya Chapman, Narasimha Marella, Samuel C McNeely, Jennifer R Brown
Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial. Blood (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Lindsey Elizabeth Roeker, Maral DerSarkissian, Kellie Ryan, Yan Chen, Mei Sheng Duh, Svea K Wahlstrom, Shweta Hakre, Louise Yu, Helen Guo, Anthony Mato
Real-World Comparative Effectiveness of Acalabrutinib and Ibrutinib in Patients with Chronic Lymphocytic Leukemia. Blood advances (2023)
Christine E Ryan, Matthew S Davids, Richard Hermann, Mina Shahkarami, Juliana Biondo, Sarang Abhyankar, Hasan Alhasani, Jeff P Sharman, Anthony R Mato, Lindsey Elizabeth Roeker
MAJIC: a phase III trial of acalabrutinib + venetoclax versus venetoclax + obinutuzumab in previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma. Future oncology (London, England) (2022)
Eric Wang, Xiaoli Mi, Meghan C Thompson, Skye Montoya, Ryan Q Notti, Jumana Afaghani, Benjamin H Durham, Alex Penson, Matthew T Witkowski, Sydney X Lu, Jessie Bourcier, Simon J Hogg, Caroline Erickson, Dan Cui, Hana Cho, Michael Singer, Tulasigeri M Totiger, Sana Chaudhry, Mark Geyer, Alvaro J Alencar, Adam J Linley, M Lia Palomba, Catherine C Coombs, Jae H Park, Andrew Zelenetz, Lindsey Elizabeth Roeker, Mary Rosendahl, Donald E Tsai, Kevin Ebata, Barbara Brandhuber, David M Hyman, Iannis Aifantis, Anthony Mato, Justin Taylor, Omar Abdel-Wahab
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors. The New England journal of medicine 386 (8) (2022)
Lindsey Elizabeth Roeker, Tatyana A Feldman, Jacob D Soumerai, Victoria Falco, Gail Panton, Colleen Dorsey, Andrew D Zelenetz, Lorenzo Falchi, Jae H Park, David J Straus, Camila Pena Velasquez, Sonia Lebowitz, Yehudit Fox, Kristen Battiato, Carissa Laudati, Meghan C Thompson, Elizabeth McCarthy, Sabrina Kdiry, Rosalba Martignetti, Teja Turpuseema, Michelle Purdom, Dana Paskalis, Hari P Miskin, Peter Sportelli, Lori A Leslie, Anthony R Mato
Adding Umbralisib and Ublituximab (U2) to Ibrutinib in Patients with CLL: A Phase II Study of an MRD-Driven Approach. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (18) (2022)
Meghan C Thompson, Rosemary A Harrup, Catherine C Coombs, Lindsey Elizabeth Roeker, Jeffrey J Pu, Michael Y Choi, Paul M Barr, John N Allan, Martin Simkovic, Lori Leslie, Joanna Rhodes, Elise A Chong, Manali Kamdar, Alan Skarbnik, Frederick Lansigan, Brittany McCall, Khalid Saja, Martin J S Dyer, Harriet Sarah Walter, Marcus Lefebure, Maria Thadani-Mulero, Michelle Boyer, Juliana Biondo, Kavita Sail, Beenish S Manzoor, Richard Furman, Kurt S Bantilan, Andre H Goy, Tatyana Feldman, Dominic LaBella, Stephen J Schuster, Jae Park, Lia Palomba, Andrew D Zelenetz, Toby Andrew Eyre, Arnon P Kater, John Francis Seymour, Anthony R Mato
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen. Blood advances 6 (15) (2022)
Oscar B Lahoud, Sean M Devlin, Molly A Maloy, Lindsey Elizabeth Roeker, Parastoo Bahrami Dahi, Doris M Ponce, Boglarka Gyurkocza, Guenther Koehne, James W Young, Hugo R Castro-Malaspina, Juliet N Barker, Esperanza B Papadopoulos, Ann A Jakubowski, Andrew D Zelenetz, Anthony R Mato, Sergio A Giralt, Miguel-Ángel Perales, Craig S Sauter
Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation. Blood advances 5 (14) (2021)
Lindsey Elizabeth Roeker, David A Knorr, Meghan C Thompson, Mariely Nivar, Sonia Lebowitz, Nicole Peters, Isaac Deonarine, Saddia Momotaj, Saumya Sharan, Vanessa Chanlatte, Bianca Hampton, Liana Butala, Lindsay Amato, Angela Richford, Jessica Lunkenheimer, Kristen Battiato, Carissa Laudati, Anthony R Mato
COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia. Leukemia 35 (9) (2021)
Lindsey Elizabeth Roeker, Meghan Thompson, Anthony R Mato
Current Treatment of Chronic Lymphocytic Leukemia: The Diminishing Role of Chemoimmunotherapy. Drugs 82 (2) (2021)
Lindsey Elizabeth Roeker, Toby Andrew Eyre, Meghan C Thompson, Nicole Lamanna, Alexander R Coltoff, Matthew S Davids, Peter O Baker, Lori Leslie, Kerry A Rogers, John N Allan, Raul Cordoba, Alberto López-García, Darko Antic, John M Pagel, Nicolás Martinez-Calle, Jose Antonio Garcia-Marco, Jose-Ángel Hernández-Rivas, Fatima Miras, Catherine C Coombs, Anders Österborg, Lotta Hansson, Amanda N Seddon, Javier López Jiménez, Matthew R Wilson, Dima El-Sharkawi, Daniel Wojenski, Shuo Ma, Talha Munir, Susana Valenciano, Erlene Seymour, Paul M Barr, Jeffrey J Pu, Piers E M Patten, Guilherme F Perini, Scott F Huntington, Helen M Parry, Suchitra Sundaram, Alan Skarbnik, Manali Kamdar, Ryan Jacobs, Harriet Sarah Walter, Renata Walewska, Angus Broom, Sonia Lebowitz, Krista M Isaac, Craig A Portell, Inhye E Ahn, Chaitra S Ujjani, Mazyar Shadman, Sigrid S Skånland, Elise A Chong, Anthony R Mato
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood 138 (18) (2021)
Lindsey Elizabeth Roeker, David A Knorr, Melissa S Pessin, Lakshmi V Ramanathan, Meghan C Thompson, Lori A Leslie, Andrew D Zelenetz, Anthony R Mato
Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia. Leukemia 34 (11) (2020)